EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Preeclampsia in pregnant women with COVID-19: a prospective cohort study from two tertiary hospitals in Southern Brazil

Narcizo Lec Sobieray, Newton S Carvalho, Cynthia F Klas, Isabella N Furuie, Jullie A Chiste, Cyllian A Fugaça, Jessica S Longo, Juliana D Oliveira, Sérgio L Padilha

PeerJ · 2024

DOI: 10.7717/peerj.17481 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PeerJ, 2024. Verfasst von Narcizo Lec Sobieray und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology and Postgraduate Program in Internal Medicine and Health Sciences, Universidade Federal do Paraná, Curitiba, …. Hauptthemen laut MEDLINE: Pre-Eclampsia, COVID-19, Tertiary Care Centers, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FUNPAR Foundation, Ministry of Education—Brazil, Federal University of Paraná.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID-19 is an infectious pathology that shows vascular changes during pregnancy, as well as in the placentas. The main objectives of this study were to estimate the prevalence and the risk factors for preeclampsia in hospitalized pregnant women with COVID-19. As well as comparing maternal and perinatal outcomes in hospitalized pregnant women with COVID-19 and preeclampsia with those without preeclampsia.

Methods

Prospective cohort study of 100 hospitalized pregnant women from two tertiary hospitals, diagnosed with COVID-19, and divided into two groups: PE+ group (pregnant women with COVID-19 and preeclampsia) and PE- group (pregnant women with COVID-19 without preeclampsia). These pregnant women had prevalence, risk factors, maternal and perinatal data analyzed.

Results

The prevalence of preeclampsia was 11%. Severe COVID-19 was the main risk factor for preeclampsia (OR = 8.18 [CI 1.53–43.52]), as well as fetal growth restriction was the main perinatal outcome (OR = 8.90 [CI 1.52–38.4]). Comorbidities were more frequent in the PE+ group (63.6% vs 31.5%, p = 0.03), as well as prematurity (81.8% vs 41.6%, p = 0.02), low birth weight (63.6% vs 24.7%, p = 0.01), and the need for neonatal intensive care admission of the newborn (63.6% vs 27.0%, p = 0.03). Pregnant women with PE had twice as long a length of stay in the intensive care unit (RR = 2.35 [CI 1.34–4.14]). Although maternal mortality was more frequent among pregnant women with PE, it was not statistically significant.

Conclusions

Prevalence of preeclampsia in hospitalized pregnant women with COVID-19 was 11%. Severe COVID-19 was the main risk factor for preeclampsia and associated comorbidities increased the risk for developing preeclampsia. Long length of stay in the intensive care unit was the main maternal outcome and fetal growth restriction was the main perinatal outcome of preeclampsia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaCOVID-19Tertiary Care CentersPregnancy Complications, InfectiousPregnancy OutcomeSARS-CoV-2HumansPregnancyFemaleBrazilProspective StudiesAdultRisk FactorsPrevalenceInfant, NewbornFetal Growth RetardationComorbidity

Stichwörter der Autor:innen

COVID-19Epidemiological dataMaternal outcomePerinatal outcomePreeclampsiaRisk factor

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology and Postgraduate Program in Internal Medicine and Health Sciences, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.
  • Department of Obstetrics and Gynecology and Postgraduate Program in Obstetrics and Gynecology, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.
  • Department of Obstetrics and Gynecology, Hospital of Clinics Complex-CHC-UFPR-EBSERH, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.
  • Department of Obstetrics and Gynecology, Hospital Nossa Senhora das Graças, Curitiba, Paraná, Brazil.
  • Department of Internal Medicine and Postgraduate Program in Internal Medicine and Helath Sciences, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.

Förderung

  • FUNPAR Foundation
  • Ministry of Education—Brazil
  • Federal University of Paraná
  • The FUNPAR Foundation, Ministry of Education—Brazil and Federal University of Paraná

Zitieren

APA

Sobieray, N. L., Carvalho, N. S., Klas, C. F., Furuie, I. N., Chiste, J. A., Fugaça, C. A., Longo, J. S., Oliveira, J. D., & Padilha, S. L. (2024). Preeclampsia in pregnant women with COVID-19: a prospective cohort study from two tertiary hospitals in Southern Brazil. PeerJ. https://doi.org/10.7717/peerj.17481

Vancouver

Sobieray NL, Carvalho NS, Klas CF, Furuie IN, Chiste JA, Fugaça CA, et al. Preeclampsia in pregnant women with COVID-19: a prospective cohort study from two tertiary hospitals in Southern Brazil. PeerJ. 2024. doi:10.7717/peerj.17481

BibTeX
@article{Sobieray2024,
  author = {Sobieray, Narcizo Lec and Carvalho, Newton S and Klas, Cynthia F and Furuie, Isabella N and Chiste, Jullie A and Fugaça, Cyllian A and Longo, Jessica S and Oliveira, Juliana D and Padilha, Sérgio L},
  title = {Preeclampsia in pregnant women with COVID-19: a prospective cohort study from two tertiary hospitals in Southern Brazil},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.17481}
}
Kostenlos starten →